near term catalysts.
1/ announce renal PCK disease drug 10B market ($US) . This may have a business dev deal in the wings.
2/ progress RP11 Phase 1 trial to next dose ( and therapeutic dose) level. remember, this may have efficacy implications, the countdown to noticing the effect starts at this time.
3/ADOA submission to FDA getting closer.
I am sure there are others.
Something definitely happened last week to wake up the buyers.
near term catalysts.1/ announce renal PCK disease drug 10B...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.020(1.74%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.18 | $1.17 | $4.269K | 3.647K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10256 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 10259 | 5 |
View Market Depth
| Last trade - 10.11am 19/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |